Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Login
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press/Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
A study to evaluate safety, reactogenicity and immunogenicity of GSK Biologicals’ RSV investigational vaccine based on viral proteins encoded by chimpanzee-derived adenovector (ChAd155-RSV) (GSK3389245A) in infants.
Richmond, Peter
(Investigator 01)
Paediatrics
Overview
Project Details
Status
Finished
Effective start/end date
8/09/19
→
7/09/20
Funding
GlaxoSmithKline:
A$134,636.00
View all
View less